Red blood cell membrane fluidity in the etiology of multiple sclerosis

Journal of Membrane Biology

Volumn 232, Issue 1-3, 2009, Pages 25-34

  Hon, Gloudina M ^a   Hassan, Mogamat S ^a   Van Rensburg, Susan J ^b   Abel, Stefan ^c   Van Jaarsveld, Paul ^c   Erasmus, Rajiv T ^b   Matsha, Tandi ^a  

^a CAPE PENINSULA UNIVERSITY OF TECHNOLOGY   (South Africa)

^b NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^c SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

Author keywords

Biochemistry; Cytoskeleton; Erythrocyte membrane; Fatty acid binding through membranes; Membrane; Structure

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; FATTY ACID; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID;

ADULT; ARTICLE; CELL MEMBRANE FLUIDITY; CLINICAL ARTICLE; COLORIMETRY; CONTROLLED STUDY; DISEASE SEVERITY; ENZYMATIC ASSAY; ERYTHROCYTE MEMBRANE; EXPANDED DISABILITY STATUS SCALE; FATTY ACID ANALYSIS; FEMALE; FUNCTIONAL SYSTEM SCORE; GAS CHROMATOGRAPHY; HUMAN; HUMAN CELL; INFLAMMATION; LIPID COMPOSITION; LIQUID CRYSTAL; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT; SCORING SYSTEM;

C-REACTIVE PROTEIN; CHOLESTEROL; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTE MEMBRANE; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; MEMBRANE FLUIDITY; MEMBRANE LIPIDS; MULTIPLE SCLEROSIS; PHOSPHATIDYLETHANOLAMINES;

EID: 73749085672     PISSN: 00222631     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00232-009-9213-1     Document Type: Article

References (42)

1. 2, epinephrine, and isoproterenol alter deformability Science 174 512 514 10.1126/science.174.4008.512 1:CAS:528:DyaE38XlsVGhsA%3D%3D 5110430
2. HG Allen JC Allen LC Boyd BP Alston-Mills GP Fenner 2006 Determination of membrane lipid differences in insulin resistant diabetes mellitus type 2 in whites and blacks Nutrition 22 1096 1102 10.1016/j.nut.2006.07.007 1:CAS:528:DC%2BD28Xht1SjsrjI 17095403 (Pubitemid 44692444)
3. Y Barenholz 2002 Cholesterol and other membrane active sterols: from membrane evolution to "rafts" Prog Lipid Res 41 1 5 10.1016/S0163-7827(01)00016-9 1:CAS:528:DC%2BD3MXptlGjt7g%3D 11694266 (Pubitemid 32994809)
4. Y Barenholz TE Thompson 1999 Sphingomyelin: biophysical aspects Chem Phys Lipids 102 29 34 10.1016/S0009-3084(99)00072-9 1:CAS:528:DyaK1MXmt1emt7o%3D 11001558 (Pubitemid 29438656)
5. JM Boggs MA Moscarello 1980 A comparison of composition and fluidity of multiple sclerosis and normal myelin Neurochem Res 5 319 336 10.1007/BF00964620 1:CAS:528:DyaL3cXktVGnu70%3D 6246464
6. W Brück 2005 Clinical implications of neuropathological findings in multiple sclerosis J Neurol 252 III/10 III/14 10.1007/s00415-005-2011-5 (Pubitemid 41355779)
7. Caret RL, Denniston KJ, Topping JJ (1997) Lipids and their functions in biochemical systems. In: Wheatley CH (ed) Principles and applications of inorganic, organic and biological chemistry. McGraw-Hill, Boston, pp 379-407
8. GD Cheravil 1984 Sialic acid and fatty acid concentrations in lymphocytes, red blood cells and from patients with multiple sclerosis J Neurol Sci 63 1 10 10.1016/0022-510X(84)90104-7 (Pubitemid 14178549)
9. LS Chia JE Thompson MA Moscarello 1984 Alteration of lipid-phase behavior in multiple sclerosis myelin revealed by wide-angle X-ray diffraction Proc Natl Acad Sci USA 81 1871 1874 10.1073/pnas.81.6.1871 1:CAS:528:DyaL2cXhvV2ktL4%3D 6584921
10. J Folch M Lees GH Sloane-Stanley 1957 A simple method for the isolation and purification of total lipids from animal tissues J Biol Chem 226 497 509 1:STN:280:DyaG2s%2FnsFCjtw%3D%3D 13428781
11. G Giovannoni JW Thorpe D Kidd BE Kendall IF Moseley AJ Thompson G Keir DH Miller M Feldmann EJ Thompson 1996 Soluble E-selectin in multiple sclerosis: raised concentrations in patients with primary progressive disease J Neurol Neurosurg Psychiatry 60 20 26 10.1136/jnnp.60.1.20 1:STN:280: DyaK287ltFWksA%3D%3D 8558145
12. G Giovannoni DH Miller NA Losseff M Sailer N Lewellyn-Smith AJ Thompson EJ Thompson 2001 Serum inflammatory markers and clinical/MRI markers of disease progression in multiple sclerosis J Neurol 248 487 495 10.1007/s004150170158 1:CAS:528:DC%2BD3MXotlyqtrg%3D 11499639 (Pubitemid 32663880)
13. E Göpfert S Pytlik H Debuch 1980 2′,3′-Cyclic nucleotide 3′-phosphohydrolase and lipids of myelin from multiple sclerosis and normal brains J Neurochem 34 732 739 10.1111/j.1471-4159.1980.tb11205.x 6243698 (Pubitemid 10165095)
14. C Hamai T Yang S Kataoka PS Cremer SM Musser 2006 Effect of average phospholipid curvature on supported bilayer formation on glass by vesicle fusion Biophys J 90 1241 1248 10.1529/biophysj.105.069435 1:CAS:528: DC%2BD28Xhslars78%3D 16299084
15. LS Harbige MK Sharief 2007 Polyunsaturated fatty acids in the pathogenesis and treatment of multiple sclerosis Br J Nutr 98 S46 S53 10.1017/S0007114507833010 1:CAS:528:DC%2BD2sXhtlGmtr%2FK 17922959 (Pubitemid 47543477)
16. K Harlos H Eibl 1981 Hexagonal phases in phospholipids with saturated chains: phosphatidylethanolamines and phosphatidic acids Biochemistry 20 2888 2892 10.1021/bi00513a027 1:CAS:528:DyaL3MXktVahsLs%3D 7248255
17. 2 J Biol Chem 276 22722 22731 10.1074/jbc.M010879200 1:CAS:528:DC%2BD3MXkvVamtrc%3D 11294853
18. JR Hazel EE Williams 1990 The role of alterations in membrane lipid composition in enabling physiological adaptation of organisms to their physical environment Prog Lipid Res 29 167 227 10.1016/0163-7827(90)90002-3 1:CAS:528:DyaK3MXltVylt7k%3D 2131463
19. RT Holman SB Johnson E Kokmen 1989 Deficiencies of polyunsaturated fatty acids and replacement by nonessential fatty acids in plasma lipids in multiple sclerosis Proc Natl Acad Sci USA 86 4720 4724 10.1073/pnas.86.12.4720 1:CAS:528:DyaL1MXkslGrsLk%3D 2734316
20. GM Hon MS Hassan SJ Van Rensburg S Abel W De Marais P Van Jaarsveld CM Smuts F Henning RT Erasmus T Matsha 2009 Erythrocyte membrane fatty acids in patients with multiple sclerosis Mult Scler 15 759 762 10.1177/1352458509103321 1:CAS:528:DC%2BD1MXovFOrsr0%3D 19435752
21. GM Hon MS Hassan SJ Van Rensburg S Abel W De Marais P Van Jaarsveld CM Smuts F Henning RT Erasmus T Matsha 2009 Immune cell membrane fatty acids and inflammatory marker, C-reactive protein in patients with multiple sclerosis Br J Nutr 19 1 7
22. Hon GM, Hassan MS, Van Rensburg SJ, Abel S, Erasmus RT Matsha T (2009c) Membrane saturated fatty acids and disease progression in multiple sclerosis patients. Metab Brain Dis (in press)
23. Horrobin DF (1999) The phospholipid concept of psychiatric disorders and its relationship to the neurodevelopmental concept of schizophrenia. In: Peet M, Glen I, Horrobin DF (eds) Phospholipid spectrum disorder in psychiatry. Marius Press, Carnforth, UK, pp 3-16
24. K Itaya M Ui 1966 A new micromethod for the colorimetric determination of inorganic phosphate Clin Chim Acta 14 361 366 10.1016/0009-8981(66)90114-8 1:CAS:528:DyaF28Xks1OitLc%3D 5970965
25. Koay ESC, Walmsley N (1999) Plasma lipids and lipoproteins. In: Koay ESC, Walmsley N (eds) A primer of chemical pathology. World Scientific, Singapore, pp 191-211
26. J Kurantsin-Mills N Samji MA Moscarello JM Boggs 1982 Comparison of membrane structure, osmotic fragility, and morphology of multiple sclerosis and normal erythrocytes Neurochem Res 7 1523 1540 10.1007/BF00965095 1:STN:280:DyaL3s7pt1Omuw%3D%3D 6302539
27. JF Kurtzke 1983 Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS) Neurology 33 1444 1452 1:STN:280:DyaL2c%2FktValsQ%3D%3D 6685237
28. S Labrouche G Freyburger H Gin MR Boisseau C Cassagne 1996 Changes in phospholipid composition of blood cell membranes (erythrocyte, platelet, and polymorphonuclear) in different types of diabetes-clinical and biological correlations Metabolism 45 57 71 10.1016/S0026-0495(96)90200-0 1:CAS:528:DyaK28Xkt1ShtA%3D%3D 8544778 (Pubitemid 26104268)
29. FA Manzoli S Stefoni L Manzoli-Guidotti M Barbieri 1970 The fatty acids of myelin phospholipids FEBS Lett 10 317 320 10.1016/0014-5793(70)80462-8 1:CAS:528:DyaE3MXktVSntA%3D%3D 11945422
30. X Navarro R Segura 1989 Red blood cell fatty acids in multiple sclerosis Acta Neurol Scand 79 32 37 10.1111/j.1600-0404.1989.tb03706.x 1:STN:280:DyaL1M7ovFKitA%3D%3D 2929272
31. S Nightingale E Woo AD Smith JM French MM Gale HM Sinclair D Bates DA Shaw 1990 Red blood cell and adipose tissue fatty acids in mild inactive multiple sclerosis Acta Neurol Scand 82 43 50 10.1111/j.1600-0447.1990.tb05324.x 1:CAS:528:DyaK3MXkt1Ojuro%3D 2239137
32. B Ohler K Graf R Bragg T Lemons R Coe C Genain J Israelachvili C Husted 2004 Role of lipid interactions in autoimmune demyelination Biochim Biophys Acta 1688 10 17 1:CAS:528:DC%2BD2cXltV2iug%3D%3D 14732476
33. S Pollock MJ Harrison G O'Connell 1982 Erythrocyte deformability in multiple sclerosis J Neurol Neurosurg Psychiatry 45 762 10.1136/jnnp.45.8.762 1:STN:280:DyaL3s%2Fjt1Grsw%3D%3D 7131008
34. W Richmond 1973 Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum Clin Chem 19 1350 1356 1:CAS:528:DyaE2cXht12ksrg%3D 4757363
35. J Sellner I Greeve HP Mattle 2008 Atorvastatin decreases high-sensitivity C-reactive protein in multiple sclerosis Mult Scler 14 981 984 10.1177/1352458508091368 1:CAS:528:DC%2BD1cXhtFSgs7vN 18573823
36. CM Smuts HFH Weich MJ Weight M Faber M Kruger CJ Lombard AJS Benade 1994 Free cholesterol concentrations in the high-density lipoprotein subfraction-3 as a risk indicator in patients with angiographically documented coronary artery disease Coron Artery Dis 5 331 338 10.1097/00019501-199404000-00009 1:STN:280:DyaK2czhvFGntA%3D%3D 8044345
37. PJ Van Jaarsveld CM Smuts HY Tichelaar M Kruger AJS Benadé 2000 Effect of palm oil on plasma lipoprotein concentrations and plasma low-density lipoprotein composition in non-human primates Int J Food Sci Nutr 51 S21 S30 10.1080/096374800750049549 11271853
38. ME Van Meeteren CE Teunissen CD Dijkstra EA Van Tol 2005 Antioxidants and polyunsaturated fatty acids in multiple sclerosis Eur J Clin Nutr 59 1347 1361 10.1038/sj.ejcn.1602255 16118655 (Pubitemid 43135149)
39. Voet D, Voet JG (1995) Lipids and membranes. In: Voet D, Voet JG (eds) Biochemistry. Wiley, New York, pp 277-329
40. EE Williams 1998 Membrane lipids: what membrane physical properties are conserved during physiochemically-induced membrane restructuring? Am Zool 38 280 290 1:CAS:528:DyaK1cXjt1yksLc%3D
41. R Wilson DR Tocher 1991 Lipid and fatty acid composition is altered in plaque tissue from multiple sclerosis brain compared with normal brain white matter Lipids 26 9 15 10.1007/BF02544017 1:CAS:528:DyaK3MXhsVSqs7s%3D 2051890
42. N Zamaria 2004 Alteration of polyunsaturated fatty acid status and metabolism in health and disease Reprod Nutr Dev 44 273 282 10.1051/rnd:2004034 1:CAS:528:DC%2BD2cXoslGlsbk%3D 15460166 (Pubitemid 39198969)